Teva Pharmaceutical Industries (TEVA) EPS (Basic) Growth (3y) (2012 - 2026)
Teva Pharmaceutical Industries (TEVA) EPS (Basic) Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 15.17% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 3.18% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 2.42% |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 12.25% |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | -35.06% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 13.47% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 36.60% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | -86.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.17% |
| Mar 31, 2026 | 50.53% |
| Dec 31, 2025 | 32.79% |
| Sep 30, 2025 | 86.99% |
| Jun 30, 2025 | 43.87% |
| Mar 31, 2025 | 30.45% |
| Dec 31, 2024 | -21.07% |
| Sep 30, 2024 | -48.13% |
| Jun 30, 2024 | -82.33% |
| Mar 31, 2024 | 83.65% |
| Dec 31, 2023 | -139.38% |
| Sep 30, 2023 | 26.35% |
| Jun 30, 2023 | -102.79% |
| Mar 31, 2023 | -77.52% |
| Dec 31, 2022 | -140.55% |
| Sep 30, 2022 | 30.07% |
| Jun 30, 2022 | 26.51% |
| Mar 31, 2022 | -108.96% |
| Dec 31, 2021 | 99.64% |
| Sep 30, 2021 | 44.78% |